Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05353933Completed
Randomised, open-label trial (2 arms), sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Primary endpoints: Change in Gastroesophageal Reflux Disease Questionnaire Score at Day 28 and Change in Proportion of GERD Typical Symptoms Absence at Day 28. Started May 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05353933.